Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma

Authors

Keywords

Journal

Volume 5, Issue 3, Pages 255-262

Publisher

Springer Nature

Online

2011-04-06

DOI

10.1007/s11764-011-0178-6

References

View 5 related references

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started